Last 12 months
Inside the activity.
3 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 3 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 08, 2022 Filed Feb 10, 2022 23:48 UTC |
Sleyster ScottExecutive Vice President
|
Grant2022 Performance Shares · Derivative | 27,199 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004327 · form4.xml · derivative · entry 5 Sleyster Scott · CIK 0001555872 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,199 Underlying: Common Stock · 27,199 shares Expires not disclosed F7 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F8 · derivative.exercise_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2025 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2022 through 2024 performance period. F8 · derivative.expiration_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2025 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2022 through 2024 performance period. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:48 UTC |
Sleyster ScottExecutive Vice President
|
Grant2022 Restricted Stock Units · Derivative | 9,067 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004327 · form4.xml · derivative · entry 4 Sleyster Scott · CIK 0001555872 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,067 Underlying: Common Stock · 9,067 shares Expires not disclosed F5 · derivative.exercise_price: The Restricted Stock Units convert to common stock on a 1 to 1 basis. F6 · derivative.exercise_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2023. F6 · derivative.expiration_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2023. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:48 UTC |
Sleyster ScottExecutive Vice President
|
Tax withholdingCommon Stock | 10,474 | $121.33 | $1,270,810.42 |
DisclosureSEC source: 0001127602-22-004327 · form4.xml · nonDerivative · entry 2 Sleyster Scott · CIK 0001555872 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,425.12 F3 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:48 UTC |
Sleyster ScottExecutive Vice President
|
Exercise / conversionCommon Stock | 22,884 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004327 · form4.xml · nonDerivative · entry 1 Sleyster Scott · CIK 0001555872 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,899.12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period F2 · shares: Includes cash settled performance units which were converted from cash to equity settlement based on a decision by the Compensation Committee. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:43 UTC |
Silitch Nicholas CSenior Vice President
|
Exercise / conversion2019 Performance Shares · Derivative | 8,998 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004326 · form4.xml · derivative · entry 6 Silitch Nicholas C · CIK 0001552178 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,998 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period F1 · derivative.exercise_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period F1 · derivative.expiration_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:43 UTC |
Silitch Nicholas CSenior Vice President
|
Grant2022 Performance Shares · Derivative | 15,001 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004326 · form4.xml · derivative · entry 5 Silitch Nicholas C · CIK 0001552178 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,001 Underlying: Common Stock · 15,001 shares Expires not disclosed F7 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F8 · derivative.exercise_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2025 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2022 through 2024 performance period. F8 · derivative.expiration_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2025 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2022 through 2024 performance period. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:43 UTC |
Silitch Nicholas CSenior Vice President
|
Grant2022 Restricted Stock Units · Derivative | 6,429 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004326 · form4.xml · derivative · entry 4 Silitch Nicholas C · CIK 0001552178 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,429 Underlying: Common Stock · 6,429 shares Expires not disclosed F5 · derivative.exercise_price: The Restricted Stock Units convert to common stock on a 1 to 1 basis. F6 · derivative.exercise_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2023. F6 · derivative.expiration_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2023. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:43 UTC |
Silitch Nicholas CSenior Vice President
|
Tax withholdingCommon Stock | 5,845 | $121.33 | $709,173.85 |
DisclosureSEC source: 0001127602-22-004326 · form4.xml · nonDerivative · entry 2 Silitch Nicholas C · CIK 0001552178 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,482 F3 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:43 UTC |
Silitch Nicholas CSenior Vice President
|
Exercise / conversionCommon Stock | 16,021 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004326 · form4.xml · nonDerivative · entry 1 Silitch Nicholas C · CIK 0001552178 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,327 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period F2 · shares: Includes cash settled performance units which were converted from cash to equity settlement based on a decision by the Compensation Committee. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:40 UTC |
SCHMIDT TIMOTHY LSenior Vice President
|
Exercise / conversion2019 Performance Shares · Derivative | 4,499 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004325 · form4.xml · derivative · entry 6 SCHMIDT TIMOTHY L · CIK 0001760181 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,499 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period F1 · derivative.exercise_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period F1 · derivative.expiration_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:40 UTC |
SCHMIDT TIMOTHY LSenior Vice President
|
Grant2022 Performance Shares · Derivative | 9,808 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004325 · form4.xml · derivative · entry 5 SCHMIDT TIMOTHY L · CIK 0001760181 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,808 Underlying: Common Stock · 9,808 shares Expires not disclosed F6 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F7 · derivative.exercise_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2025 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2022 through 2024 performance period. F7 · derivative.expiration_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2025 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2022 through 2024 performance period. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:40 UTC |
SCHMIDT TIMOTHY LSenior Vice President
|
Grant2022 Restricted Stock Units · Derivative | 4,204 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004325 · form4.xml · derivative · entry 4 SCHMIDT TIMOTHY L · CIK 0001760181 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,204 Underlying: Common Stock · 4,204 shares Expires not disclosed F4 · derivative.exercise_price: The Restricted Stock Units convert to common stock on a 1 to 1 basis. F5 · derivative.exercise_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2023. F5 · derivative.expiration_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2023. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:40 UTC |
SCHMIDT TIMOTHY LSenior Vice President
|
Tax withholdingCommon Stock | 4,214 | $121.33 | $511,284.62 |
DisclosureSEC source: 0001127602-22-004325 · form4.xml · nonDerivative · entry 2 SCHMIDT TIMOTHY L · CIK 0001760181 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,115 F3 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:40 UTC |
SCHMIDT TIMOTHY LSenior Vice President
|
Exercise / conversionCommon Stock | 8,432 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004325 · form4.xml · nonDerivative · entry 1 SCHMIDT TIMOTHY L · CIK 0001760181 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,329 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period F2 · shares: Includes cash settled performance units which were converted from cash to equity settlement based on a decision by the Compensation Committee. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:37 UTC |
Lowrey Charles FDirector · Chief Executive Officer · Chairman of the Board
|
Exercise / conversion2019 Performance Shares · Derivative | 26,671 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004324 · form4.xml · derivative · entry 6 Lowrey Charles F · CIK 0001512629 · Director · Chief Executive Officer · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,671 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period F1 · derivative.exercise_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period F1 · derivative.expiration_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:37 UTC |
Lowrey Charles FDirector · Chief Executive Officer · Chairman of the Board
|
Grant2022 Performance Shares · Derivative | 77,269 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004324 · form4.xml · derivative · entry 5 Lowrey Charles F · CIK 0001512629 · Director · Chief Executive Officer · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,269 Underlying: Common Stock · 77,269 shares Expires not disclosed F7 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F8 · derivative.exercise_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2025 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2022 through 2024 performance period. F8 · derivative.expiration_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2025 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2022 through 2024 performance period. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:37 UTC |
Lowrey Charles FDirector · Chief Executive Officer · Chairman of the Board
|
Grant2022 Restricted Stock Units · Derivative | 25,757 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004324 · form4.xml · derivative · entry 4 Lowrey Charles F · CIK 0001512629 · Director · Chief Executive Officer · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,757 Underlying: Common Stock · 25,757 shares Expires not disclosed F5 · derivative.exercise_price: The Restricted Stock Units convert to common stock on a 1 to 1 basis. F6 · derivative.exercise_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2023. F6 · derivative.expiration_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2023. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:37 UTC |
Lowrey Charles FDirector · Chief Executive Officer · Chairman of the Board
|
Tax withholdingCommon Stock | 26,408 | $121.33 | $3,204,082.64 |
DisclosureSEC source: 0001127602-22-004324 · form4.xml · nonDerivative · entry 2 Lowrey Charles F · CIK 0001512629 · Director · Chief Executive Officer · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,876 F3 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:37 UTC |
Lowrey Charles FDirector · Chief Executive Officer · Chairman of the Board
|
Exercise / conversionCommon Stock | 49,982 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004324 · form4.xml · nonDerivative · entry 1 Lowrey Charles F · CIK 0001512629 · Director · Chief Executive Officer · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,284 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period F2 · shares: Includes cash settled performance units which were converted from cash to equity settlement based on a decision by the Compensation Committee. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:33 UTC |
KAPPLER ANN MEVP and General Counsel
|
Exercise / conversion2019 Performance Shares · Derivative | 3,536 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004323 · form4.xml · derivative · entry 6 KAPPLER ANN M · CIK 0001280546 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,536 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period F1 · derivative.exercise_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period F1 · derivative.expiration_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:33 UTC |
KAPPLER ANN MEVP and General Counsel
|
Grant2022 Performance Shares · Derivative | 14,836 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004323 · form4.xml · derivative · entry 5 KAPPLER ANN M · CIK 0001280546 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,836 Underlying: Common Stock · 14,836 shares Expires not disclosed F7 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F8 · derivative.exercise_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2025 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2022 through 2024 performance period. F8 · derivative.expiration_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2025 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2022 through 2024 performance period. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:33 UTC |
KAPPLER ANN MEVP and General Counsel
|
Grant2022 Restricted Stock Units · Derivative | 4,946 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004323 · form4.xml · derivative · entry 4 KAPPLER ANN M · CIK 0001280546 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,946 Underlying: Common Stock · 4,946 shares Expires not disclosed F5 · derivative.exercise_price: The Restricted Stock Units convert to common stock on a 1 to 1 basis. F6 · derivative.exercise_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2023. F6 · derivative.expiration_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2023. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:33 UTC |
KAPPLER ANN MEVP and General Counsel
|
Tax withholdingCommon Stock | 980 | $121.33 | $118,903.40 |
DisclosureSEC source: 0001127602-22-004323 · form4.xml · nonDerivative · entry 2 KAPPLER ANN M · CIK 0001280546 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,356 F3 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:33 UTC |
KAPPLER ANN MEVP and General Counsel
|
Exercise / conversionCommon Stock | 3,314 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004323 · form4.xml · nonDerivative · entry 1 KAPPLER ANN M · CIK 0001280546 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,336 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period F2 · shares: Includes cash settled performance units which were converted from cash to equity settlement based on a decision by the Compensation Committee. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:27 UTC |
GOODMAN STACEYExecutive Vice President
|
Grant2022 Performance Shares · Derivative | 14,836 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004320 · form4.xml · derivative · entry 3 GOODMAN STACEY · CIK 0001661379 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,836 Underlying: Common Stock · 14,836 shares Expires not disclosed F4 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F5 · derivative.exercise_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2025 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2022 through 2024 performance period. F5 · derivative.expiration_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2025 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2022 through 2024 performance period. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:27 UTC |
GOODMAN STACEYExecutive Vice President
|
Grant2022 Restricted Stock Units · Derivative | 4,946 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004320 · form4.xml · derivative · entry 2 GOODMAN STACEY · CIK 0001661379 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,946 Underlying: Common Stock · 4,946 shares Expires not disclosed F2 · derivative.exercise_price: The Restricted Stock Units convert to common stock on a 1 to 1 basis. F3 · derivative.exercise_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2023. F3 · derivative.expiration_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2023. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:25 UTC |
FALZON ROBERTEVP and Vice Chairman
|
Exercise / conversion2019 Performance Shares · Derivative | 21,209 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004319 · form4.xml · derivative · entry 7 FALZON ROBERT · CIK 0001256465 · EVP and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,209 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period F1 · derivative.exercise_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period F1 · derivative.expiration_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:25 UTC |
FALZON ROBERTEVP and Vice Chairman
|
Grant2022 Performance Shares · Derivative | 61,815 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004319 · form4.xml · derivative · entry 6 FALZON ROBERT · CIK 0001256465 · EVP and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,815 Underlying: Common Stock · 61,815 shares Expires not disclosed F6 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F7 · derivative.exercise_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2025 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2022 through 2024 performance period. F7 · derivative.expiration_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2025 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2022 through 2024 performance period. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:25 UTC |
FALZON ROBERTEVP and Vice Chairman
|
Grant2022 Restricted Stock Units · Derivative | 20,605 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004319 · form4.xml · derivative · entry 5 FALZON ROBERT · CIK 0001256465 · EVP and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,605 Underlying: Common Stock · 20,605 shares Expires not disclosed F4 · derivative.exercise_price: The Restricted Stock Units convert to common stock on a 1 to 1 basis. F5 · derivative.exercise_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2023. F5 · derivative.expiration_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2023. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:25 UTC |
FALZON ROBERTEVP and Vice Chairman
|
Tax withholdingCommon Stock | 19,292 | $121.33 | $2,340,698.36 |
DisclosureSEC source: 0001127602-22-004319 · form4.xml · nonDerivative · entry 2 FALZON ROBERT · CIK 0001256465 · EVP and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,947 F3 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:25 UTC |
FALZON ROBERTEVP and Vice Chairman
|
Exercise / conversionCommon Stock | 37,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004319 · form4.xml · nonDerivative · entry 1 FALZON ROBERT · CIK 0001256465 · EVP and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,239 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period F2 · shares: Includes cash settled performance units which were converted from cash to equity settlement based on a decision by the Compensation Committee. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:20 UTC |
Axel RobertSVP and Controller
|
Exercise / conversion2019 Performance Shares · Derivative | 2,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004318 · form4.xml · derivative · entry 6 Axel Robert · CIK 0001602678 · SVP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period. F1 · derivative.exercise_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period. F1 · derivative.expiration_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:20 UTC |
Axel RobertSVP and Controller
|
Grant2022 Performance Shares · Derivative | 4,039 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004318 · form4.xml · derivative · entry 5 Axel Robert · CIK 0001602678 · SVP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,039 Underlying: Common Stock · 4,039 shares Expires not disclosed F7 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F8 · derivative.exercise_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2025 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2022 through 2024 performance period. F8 · derivative.expiration_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2025 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2022 through 2024 performance period. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:20 UTC |
Axel RobertSVP and Controller
|
Grant2022 Restricted Stock Units · Derivative | 1,731 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004318 · form4.xml · derivative · entry 4 Axel Robert · CIK 0001602678 · SVP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,731 Underlying: Common Stock · 1,731 shares Expires not disclosed F5 · derivative.exercise_price: The Restricted Stock Units convert to common stock on a 1 to 1 basis. F6 · derivative.exercise_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2023. F6 · derivative.expiration_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2023. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:20 UTC |
Axel RobertSVP and Controller
|
Tax withholdingCommon Stock | 1,262 | $121.33 | $153,118.46 |
DisclosureSEC source: 0001127602-22-004318 · form4.xml · nonDerivative · entry 2 Axel Robert · CIK 0001602678 · SVP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,373 F3 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:20 UTC |
Axel RobertSVP and Controller
|
Exercise / conversionCommon Stock | 4,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004318 · form4.xml · nonDerivative · entry 1 Axel Robert · CIK 0001602678 · SVP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period. F2 · shares: Includes cash settled performance units which were converted from cash to equity settlement based on a decision by the Compensation Committee. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:17 UTC |
Alziari LucienExecutive Vice President
|
Exercise / conversion2019 Performance Shares · Derivative | 7,231 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004317 · form4.xml · derivative · entry 5 Alziari Lucien · CIK 0001303114 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,231 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period. F1 · derivative.exercise_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period. F1 · derivative.expiration_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:17 UTC |
Alziari LucienExecutive Vice President
|
Grant2022 Performance Shares · Derivative | 15,454 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004317 · form4.xml · derivative · entry 4 Alziari Lucien · CIK 0001303114 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,454 Underlying: Common Stock · 15,454 shares Expires not disclosed F6 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F7 · derivative.exercise_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2025 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2022 through 2024 performance period. F7 · derivative.expiration_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2025 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2022 through 2024 performance period. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:17 UTC |
Alziari LucienExecutive Vice President
|
Grant2022 Restricted Stock Units · Derivative | 5,152 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004317 · form4.xml · derivative · entry 3 Alziari Lucien · CIK 0001303114 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,152 Underlying: Common Stock · 5,152 shares Expires not disclosed F4 · derivative.exercise_price: The Restricted Stock Units convert to common stock on a 1 to 1 basis. F5 · derivative.exercise_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2023. F5 · derivative.expiration_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2023. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:17 UTC |
Alziari LucienExecutive Vice President
|
Tax withholdingCommon Stock | 4,184 | $121.33 | $507,644.72 |
DisclosureSEC source: 0001127602-22-004317 · form4.xml · nonDerivative · entry 2 Alziari Lucien · CIK 0001303114 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,249 F3 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:17 UTC |
Alziari LucienExecutive Vice President
|
Exercise / conversionCommon Stock | 13,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004317 · form4.xml · nonDerivative · entry 1 Alziari Lucien · CIK 0001303114 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,433 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period. F2 · shares: Includes cash settled performance units which were converted from cash to equity settlement based on a decision by the Compensation Committee. Read SEC document |
| February 08, 2022 Filed Jul 13, 2022 18:13 UTC Amendment |
TANJI KENNETHEVP and CFO
|
Exercise / conversionCommon Stock | 15,658 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-019256 · form4a.xml · nonDerivative · entry 1 TANJI KENNETH · CIK 0001760674 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,292 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Correcting an amount that was erroneously reported as a disposition instead of an acquisition. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 14:46 UTC |
SCHMIDT TIMOTHY LSenior Vice President
|
Exercise / conversion2013 Employee Stock Option (Right to Buy) · Derivative | 10,902 | $0.00 Strike: $57.00 | $0.00 |
DisclosureSEC source: 0001127602-22-003878 · form4.xml · derivative · entry 7 SCHMIDT TIMOTHY L · CIK 0001760181 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,902 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2021. F5 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 12, 2014. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 14:46 UTC |
SCHMIDT TIMOTHY LSenior Vice President
|
Exercise / conversion8/15/2012 Employee Stock Option (Right to Buy) · Derivative | 3,811 | $0.00 Strike: $54.00 | $0.00 |
DisclosureSEC source: 0001127602-22-003878 · form4.xml · derivative · entry 6 SCHMIDT TIMOTHY L · CIK 0001760181 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,811 shares Expires 2022-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2021. F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on August 15, 2013. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 14:46 UTC |
SCHMIDT TIMOTHY LSenior Vice President
|
SaleCommon Stock | 10,902 | $120.00 | $1,308,240.00 |
DisclosureSEC source: 0001127602-22-003878 · form4.xml · nonDerivative · entry 4 SCHMIDT TIMOTHY L · CIK 0001760181 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,897 F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2021. F2 · balance_after: Following the transaction reported on this Form 4, Mr. Schmidt continues to hold 12,897 shares directly and 252 shares indirectly in a 401(k) account. Mr. Schmidt also holds an additional 7,308 vested stock options, 7,597 unvested stock options, 6,264 restricted stock units and 32,374 target performance shares (the exact number awarded being dependent on achievement of performance goals). Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 14:46 UTC |
SCHMIDT TIMOTHY LSenior Vice President
|
Exercise / conversionCommon Stock | 10,902 | $57.00 | $621,414.00 |
DisclosureSEC source: 0001127602-22-003878 · form4.xml · nonDerivative · entry 3 SCHMIDT TIMOTHY L · CIK 0001760181 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,799 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2021. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 14:46 UTC |
SCHMIDT TIMOTHY LSenior Vice President
|
SaleCommon Stock | 3,811 | $120.00 | $457,320.00 |
DisclosureSEC source: 0001127602-22-003878 · form4.xml · nonDerivative · entry 2 SCHMIDT TIMOTHY L · CIK 0001760181 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,897 F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2021. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 14:46 UTC |
SCHMIDT TIMOTHY LSenior Vice President
|
Exercise / conversionCommon Stock | 3,811 | $54.00 | $205,794.00 |
DisclosureSEC source: 0001127602-22-003878 · form4.xml · nonDerivative · entry 1 SCHMIDT TIMOTHY L · CIK 0001760181 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2021. Read SEC document |
| January 12, 2022 Filed Jan 13, 2022 19:38 UTC |
SCOVANNER DOUGLAS ADirector
|
Exercise / conversionNotional Shares - Optional · Derivative | 1,312 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-001443 · form4.xml · derivative · entry 2 SCOVANNER DOUGLAS A · CIK 0001205002 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,661 Underlying: Common Stock · 1,312 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each notional share - optional represents a deferred stock unit and entitles the holder thereof with the right to receive one share of Issuer common stock or the cash value thereof under the Issuer's deferred compensation plan for non-employee directors. F1 · kind: Nondiscretionary transaction executed pursuant to the issuer's deferred compensation plan for non-employee directors. F3 · derivative.exercise_date: Such shares are payable in common stock or cash, at the election of the reporting person, with payment to begin, at the election of the reporting person provided that such date shall be at least two (2) years after the end of the plan year with respect to which such elective deferrals relate. The reporting person may transfer his investment in the notional shares - optional to an alternative investment account, subject to the terms of the Issuer's deferred compensation plan for non-employee directors. F3 · derivative.expiration_date: Such shares are payable in common stock or cash, at the election of the reporting person, with payment to begin, at the election of the reporting person provided that such date shall be at least two (2) years after the end of the plan year with respect to which such elective deferrals relate. The reporting person may transfer his investment in the notional shares - optional to an alternative investment account, subject to the terms of the Issuer's deferred compensation plan for non-employee directors. Read SEC document |
| January 12, 2022 Filed Jan 13, 2022 19:38 UTC |
SCOVANNER DOUGLAS ADirector
|
Exercise / conversionCommon Stock | 1,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-001443 · form4.xml · nonDerivative · entry 1 SCOVANNER DOUGLAS A · CIK 0001205002 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Nondiscretionary transaction executed pursuant to the issuer's deferred compensation plan for non-employee directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.